VOYA Investment Management
LAB icon

VOYA Investment Management’s Standard BioTools LAB Stock Holding History

VOYA Investment Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.8K Sell
56,336
-2,066
-4% -$2.5K ﹤0.01% 2272
2025
Q4 		$74.8K Hold
58,402
– – ﹤0.01% 2299
2025
Q3 		$75.9K Sell
58,402
-28,895
-33% -$37.9K ﹤0.01% 2339
2025
Q2 		$105K Buy
87,297
+800
+0.9% +$887 ﹤0.01% 2486
2025
Q1 		$93.4K Sell
86,497
-5,405
-6% -$7.59K ﹤0.01% 2448
2024
Q4 		$161K Sell
91,902
-6,168
-6% -$11.5K ﹤0.01% 2453
2024
Q3 		$189K Sell
98,070
-4,966
-5% -$9.72K ﹤0.01% 2499
2024
Q2 		$182K Buy
+103,036
New +$252K ﹤0.01% 2499
2022
Q2 		– Sell
-29,813
Closed -$107K – 2838
2022
Q1 		$107K Hold
29,813
– – ﹤0.01% 2508
2021
Q4 		$117K Sell
29,813
-898
-3% -$4.2K ﹤0.01% 2642
2021
Q3 		$202K Hold
30,711
– – ﹤0.01% 2574
2021
Q2 		$189K Sell
30,711
-2,381
-7% -$12.7K ﹤0.01% 2626
2021
Q1 		$150K Buy
33,092
+1,848
+6% +$10.2K ﹤0.01% 2602
2020
Q4 		$187K Buy
31,244
+7,390
+31% +$48.6K ﹤0.01% 2445
2020
Q3 		$177K Hold
23,854
– – ﹤0.01% 2196
2020
Q2 		$96K Sell
23,854
-12,557
-34% -$43.7K ﹤0.01% 2343
2020
Q1 		$92K Hold
36,411
– – ﹤0.01% 2365
2019
Q4 		$127K Buy
36,411
+9,252
+34% +$32.5K ﹤0.01% 2494
2019
Q3 		$126K Hold
27,159
– – ﹤0.01% 2353
2019
Q2 		$335K Buy
27,159
+15,363
+130% +$196K ﹤0.01% 2030
2019
Q1 		$157K Sell
11,796
-2,020
-15% -$21.3K ﹤0.01% 2333
2018
Q4 		$119K Sell
13,816
-966
-7% -$7.53K ﹤0.01% 2364
2018
Q3 		$111K Sell
14,782
-1,119
-7% -$7.96K ﹤0.01% 2486
2018
Q2 		$95K Hold
15,901
– – ﹤0.01% 2529
2018
Q1 		$93K Hold
15,901
– – ﹤0.01% 2479
2017
Q4 		$94K Sell
15,901
-4,024
-20% -$22K ﹤0.01% 2514
2017
Q3 		$100K Hold
19,925
– – ﹤0.01% 2543
2017
Q2 		$80K Buy
19,925
+4,043
+25% +$19.2K ﹤0.01% 2617
2017
Q1 		$90K Hold
15,882
– – ﹤0.01% 2443
2016
Q4 		$116K Hold
15,882
– – ﹤0.01% 2423
2016
Q3 		$127 Hold
15,882
– – ﹤0.01% 2431
2016
Q2 		$143K Hold
15,882
– – ﹤0.01% 2390
2016
Q1 		$128K Hold
15,882
– – ﹤0.01% 2348
2015
Q4 		$172K Hold
15,882
– – ﹤0.01% 2349
2015
Q3 		$129K Hold
15,882
– – ﹤0.01% 2424
2015
Q2 		$384K Sell
15,882
-1,168
-7% -$36.9K ﹤0.01% 2102
2015
Q1 		$718K Sell
17,050
-2,480
-13% -$98K ﹤0.01% 1667
2014
Q4 		$659K Sell
19,530
-1,877
-9% -$53.2K ﹤0.01% 1735
2014
Q3 		$524K Hold
21,407
– – ﹤0.01% 1878
2014
Q2 		$629K Sell
21,407
-1,893
-8% -$60.7K ﹤0.01% 1811
2014
Q1 		$1.03M Hold
23,300
– – ﹤0.01% 1461
2013
Q4 		$893K Hold
23,300
– – ﹤0.01% 1535
2013
Q3 		$511K Hold
23,300
– – ﹤0.01% 1887
2013
Q2 		$407K Buy
+23,300
New +$409K ﹤0.01% 2001

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

VOYA Investment Management's LAB Position: Q1 2026 in Review

VOYA Investment Management reduced its Standard BioTools (LAB) stake by 3.5% in Q1 2026, selling an estimated $2.5K and leaving 56,336 shares worth $51.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2272.

VOYA Investment Management first reported a position in LAB in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.03M in Q1 2014. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • VOYA Investment Management held 56,336 shares of Standard BioTools worth $51.8K as of Q1 2026.
  • VOYA Investment Management sold 2,066 Standard BioTools shares in Q1 2026, an estimated $2.5K.
  • Standard BioTools made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2272 holding.
  • VOYA Investment Management first reported a position in Standard BioTools in Q2 2013 and has held it in 44 quarters since.
  • VOYA Investment Management's Standard BioTools position peaked at $1.03M in Q1 2014.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.